RedHill Biopharma Says RHB-204 Killed MAP Bacteria in Lab Studies
RedHill Biopharma announced lab-study results showing RHB-204 killed MAP bacteria.
Related stories
German Traffic Systems Shares on Track for Worst Day in 25 Years After Outlook Cut
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Kosmos Energy shares fall 13% after Q3 revenue miss
Kosmos Energy shares are down 13% after the company missed revenue expectations for the third quarter.
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Truckers Maintain Strike, Block Container Access at San Antonio Port
Truckers are maintaining a strike and blocking container access at San Antonio ahead of Chile’s peak cherry-export season.
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Twin Disc Maintains Quarterly Dividend at $0.05 per Share
Twin Disc kept its quarterly dividend at $0.05 per share, payable Dec. 1 to holders of record Nov. 18.
M impact | EQUITY | Nov 02, 2026, 02:42 PM UTC
Ryanair CEO Sees European Airfares Rising Up to 20% Next Year
Ryanair’s CEO expects European plane ticket prices may climb as much as 20% next year, with jet fuel prices rising.
L impact | EQUITY | Nov 02, 2026, 02:42 PM UTC
Sigma Lithium Plans $100M Convertible Bond Due 2031
Sigma Lithium said proceeds are intended to repay its Synergy Capital secured debt in full, with the balance for growth capital expenditure and general corporate purposes.
M impact | EQUITY | Nov 02, 2026, 02:42 PM UTC